| In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target X Wang, C Tokheim, SS Gu, B Wang, Q Tang, Y Li, N Traugh, Z Zeng, ... Cell 184 (21), 5357-5374. e22, 2021 | 90 | 2021 |
| TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response Z Zeng, CJ Wong, L Yang, N Ouardaoui, D Li, W Zhang, S Gu, Y Zhang, ... Nucleic acids research 50 (D1), D1391-D1397, 2022 | 52 | 2022 |
| Systematic characterization of mutations altering protein degradation in human cancers C Tokheim, X Wang, RT Timms, B Zhang, EL Mena, B Wang, C Chen, ... Molecular cell 81 (6), 1292-1308. e11, 2021 | 41 | 2021 |
| A universal dual mechanism immunotherapy for the treatment of influenza virus infections X Liu, B Zhang, Y Wang, HS Haymour, F Zhang, L Xu, M Srinivasarao, ... Nature communications 11 (1), 5597, 2020 | 26 | 2020 |
| Design of neuraminidase-targeted imaging and therapeutic agents for the diagnosis and treatment of influenza virus infections X Liu, W Luo, B Zhang, YG Lee, I Shahriar, M Srinivasarao, PS Low Bioconjugate Chemistry 32 (8), 1548-1553, 2021 | 9 | 2021 |
| Design, Synthesis, and Targeted Delivery of an Immune Stimulant that Selectively Reactivates Exhausted CAR T Cells JV Napoleon, B Zhang, Q Luo, M Srinivasarao, PS Low Angewandte Chemie 134 (15), e202113341, 2022 | 5 | 2022 |
| Sensitive manipulation of CAR T cell activity using a chimeric endocytosing receptor B Zhang, JV Napoleon, X Liu, Q Luo, M Srinivasarao, PS Low Journal for Immunotherapy of Cancer 8 (2), 2020 | 4 | 2020 |
| Rejuvenation of car t cell PS Low, B Zhang, JV Napoleon US Patent App. 17/266,509, 2021 | 3 | 2021 |
| Targeted Ligand-Payload Based Drug Delivery for Cell Therapy PS Low, M Srinivasarao, B Zhang US Patent App. 16/486,632, 2020 | 3 | 2020 |
| Targeted Rejuvenation of Exhausted Chimeric Antigen Receptor T Cells Regresses Refractory Solid Tumors Q Luo, JV Napoleon, X Liu, B Zhang, S Zheng, PS Low Molecular Cancer Research 20 (5), 823-833, 2022 | 2 | 2022 |
| Rejuvenation of exhausted CAR-T cells with a targeted TLR7 agonist PS Low, Q Luo, JV Napoleon, B Zhang Cancer Research 80 (16), 2020 | 1 | 2020 |
| Tumor-specific activation of folate receptor beta enables reprogramming of immune cells in the tumor microenvironment F Zhang, B Huang, SM Utturkar, W Luo, G Cresswell, SA Herr, S Zheng, ... Frontiers in Immunology 15, 1354735, 2024 | | 2024 |
| TARGETED ACTIVE SUBSTANCE RELEASE ON LIGAND PAYLOAD BASIS FOR CELL THERAPY PS Low, M SRINIVASARAO, B ZHANG | | 2020 |
| Systemic Control of CAR T Cell Activity Using a Secret Passageway Fusion Receptor B Zhang, JV Napoleon, LF Philip Cancer Research 79 (13 Suppl), Abstract nr 2316, 2019 | | 2019 |
| Design of a Private Passageway Fusion Receptor for Sensitive Control of Adoptive Cell Therapies B Zhang Purdue University, 2019 | | 2019 |
| Targeted ligand-payload based drug delivery for cell therapy PS Low, M SRINIVASARAO, B ZHANG | | 2018 |
| Systemic Control of CAR T Cell Activity Using a Secret Passageway Fusion Receptor B Zhang, M Srinivasarao, LF Philip US Patent App. PCT/US2018/018,557, 2018 | | 2018 |
Philip S. LowProfessor of Chemistry, Purdue UniversityVerified email at purdue.edu
